Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

147.31 2.03 −1.36%
Market cap
$10.6B
P/E
25.6×
Fwd P/E
20.7×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a

Align Technology, Inc. (ALGN) EPS (diluted)

Alert me on EPS (diluted)

Align Technology, Inc.'s EPS (diluted) for fiscal 2025 was $5.65, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $5.75. Over the past ten years it has ranged from $1.77 (fiscal 2015) to $22.41 (fiscal 2020); the current reading is higher than 73% of that period. Align Technology, Inc. ranks 5th of 49 Medical Instruments & Supplies companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2025 $5.65 0.53%
FY2024 $5.62 (3.27%)
FY2023 $5.81 26.03%
FY2022 $4.61 (52.43%)
FY2021 $9.69 (56.76%)
FY2020 $22.41 305.24%
FY2019 $5.53 12.40%
FY2018 $4.92 73.85%
FY2017 $2.83 21.46%
FY2016 $2.33 31.64%

Quarterly newest first

Period EPS (diluted) Change
Jun 2026 $1.51 (3.82%)
Mar 2026 $1.57 (16.93%)
Dec 2025 $1.89 142.31%
Sep 2025 $0.78 (54.65%)
42 more quarters

Against its own ten years

Low $1.77 High $22.41
Ten-year median $5.53
Current reading's percentile 73

EPS (diluted) against peers

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on ALGN